·
3 Min Read

AMA, Manatt Health unveil toolkit to combat drug overdoses

The AMA and Manatt Health release a toolkit to guide states on removing barriers to evidence-based patient care.

Press Releases
Patient and health care professional in conversation
·
4 Min Read

Insurer accountability on mental health parity is long overdue

Report finds “egregious violations” of federal law, worsening nation’s mental health and drug-overdose crises. Learn more with the AMA.

Access to Care
Exterior of an emergency room entrance
·
4 Min Read

M1s help spot emergency patients who can benefit from naloxone

Learn how first-year medical students can add value and learn about addiction medicine by screening patients to ID those at risk of an opioid-related overdose.

ChangeMedEd Initiative
·
5 Min Read

2022 a critical year to address worsening drug-overdose crisis

In the shadow of COVID-19, our nation’s drug-overdose epidemic is worsening. We need policymakers to take concrete actions in the new year to reverse this devastating trend.

series
Leadership
Leadership Viewpoints
Outdoor Emergency Room sign
·
4 Min Read

Embracing harm reduction in the emergency department

Learn about work by Phoenix emergency physicians to get naloxone directly into the hands of patients at risk of overdose.

Behavioral Health
Physician writing notes on a clipboard
·
3 Min Read

Use these new guides to help integrate behavioral health care

Whether your practice is big or small, the AMA can help you learn to integrate suicide prevention, identify substance use disorders, and more.

Behavioral Health
Ambulance
·
4 Min Read

Ending the stigma of opioid-use disorder in the emergency department

Need for cultural shift in medicine on opioid-use disorder is long overdue. Learn about one emergency physician’s journey to understanding.

Behavioral Health
Book with letters spilling out from the pages
·
4 Min Read

How language makes a difference in treating substance-use disorder

Person-first language can help patients who are struggling with addiction—and stigma. Learn more with the AMA.

Behavioral Health
·
3 Min Read

Dec. 3, 2021: State Advocacy Update

AMA urges nation’s naloxone manufactures to make product OTC and more in the latest State Advocacy Update.

Advocacy Update